- Home
- ORMP vs VANI Comparison
ORMP vs VANI Comparison
Compare ORMP & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- VANI
- Stock Information
- Founded
- ORMP 2002
- VANI 1998
- Country
- ORMP United States
- VANI United States
- Employees
- ORMP N/A
- VANI N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ORMP Health Care
- VANI Health Care
- Exchange
- ORMP Nasdaq
- VANI Nasdaq
- Market Cap
- ORMP 90.2M
- VANI 75.8M
- IPO Year
- ORMP N/A
- VANI 2014
- Fundamental
- Price
- ORMP $2.32
- VANI $1.27
- Analyst Decision
- ORMP Hold
- VANI Strong Buy
- Analyst Count
- ORMP 1
- VANI 1
- Target Price
- ORMP N/A
- VANI $4.00
- AVG Volume (30 Days)
- ORMP 96.9K
- VANI 52.2K
- Earning Date
- ORMP 11-06-2025
- VANI 11-12-2025
- Dividend Yield
- ORMP N/A
- VANI N/A
- EPS Growth
- ORMP N/A
- VANI N/A
- EPS
- ORMP N/A
- VANI N/A
- Revenue
- ORMP $2,000,000.00
- VANI N/A
- Revenue This Year
- ORMP N/A
- VANI N/A
- Revenue Next Year
- ORMP N/A
- VANI N/A
- P/E Ratio
- ORMP N/A
- VANI N/A
- Revenue Growth
- ORMP N/A
- VANI N/A
- 52 Week Low
- ORMP $1.82
- VANI $0.91
- 52 Week High
- ORMP $3.09
- VANI $1.80
- Technical
- Relative Strength Index (RSI)
- ORMP 59.64
- VANI 50.75
- Support Level
- ORMP $2.17
- VANI $1.19
- Resistance Level
- ORMP $2.45
- VANI $1.40
- Average True Range (ATR)
- ORMP 0.07
- VANI 0.07
- MACD
- ORMP 0.02
- VANI 0.01
- Stochastic Oscillator
- ORMP 61.76
- VANI 50.00
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.